Cancer and fecundity issues mandate a multidisciplinary approach
To access this article, please choose from the options below
D.deZ. holds stock in Ultrst, LLC. I.S. has nothing to disclose. I.V. has nothing to disclose. C.D. has nothing to disclose. P.T. has received grants from Pfizer and Novartis. C.C. has nothing to disclose.
PII: S0015-0282(08)04726-2
doi:10.1016/j.fertnstert.2008.12.028
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

